This is a non-core endpoint: only basic statistics are computed.
See its core counterpart CD2_INSITU_OTHER_NOS_EXALLC for full statistics.
Carcinoma in situ of other and unspecified sites
CD2_INSITU_OTHER_NOS
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
135 |
4. Check minimum number of eventsNone |
135 |
5. Include endpoints |
1176 |
6. Filter based on genotype QC (FinnGen only) |
1176 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D00-D09
- Name in latin
- Carcinoma in situ locis aliis sive non specificatis
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ of other and unspecified sites
based on the number of shared cases.
Similar with more cases:
- Carcinoma in situ of other and unspecified sites
- In situ neoplasms
- In situ neoplasms
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1176 | 236 | 940 |
| Unadjusted period prevalence (%) | 0.35 | 0.08 | 0.41 |
| Median age at first event (years) | 71.36 | 68.13 | 72.17 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1088
- Matched controls
- 10879
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
KCD02
NOMESCO Finland
Transurethral resection of bladder
124.9
323.0
698
153
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
176.8
323.0
500
52
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
150.8
323.0
672
115
UKC02
NOMESCO Finland
Cystoscopy
87.8
323.0
1023
1653
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
68.6
323.0
439
106
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
120.7
323.0
589
105
8130/2-C67.9
ICD-O-3
Papillary urothelial carcinoma, non-invasive of bladder, NOS
16384.0
323.0
711
*
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
71.0
274.4
311
61
UKC05
NOMESCO Finland
Cystoscopy and bladder biopsy
73.9
270.9
305
57
R31
ICD-10 Finland
Unspecified haematuria
11.6
256.7
579
973
ZX136
NOMESCO Finland
Intravesicalis
56.9
153.3
181
38
8120/2-C67.9
ICD-O-3
Urothelial carcinoma in situ of bladder, NOS
1511.7
139.7
133
*
KCD32
NOMESCO Finland
Cystoscopic destruction of tumour of bladder
40.9
139.7
176
51
KH1CD
NOMESCO Finland
Very extensive urinary tract ultrasound examination
27.6
110.1
153
64
WX320
NOMESCO Finland
Spinalanesthesy
4.6
106.9
493
1661
D09.0
ICD-10 Finland
Carcinoma in situ: Bladder
+∞
87.7
83
*
8130/2-C67.2
ICD-O-3
Papillary urothelial carcinoma, non-invasive of lateral wall of bladder
837.4
80.5
78
*
XKD00
NOMESCO Finland
Uroflowmetry
3.3
67.3
468
2027
TKC20
NOMESCO Finland
Catheterisation of bladder
5.0
62.9
225
538
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
3.4
62.8
386
1505
WC305
NOMESCO Finland
Simple therapy of local tumor recidive with biomodifiers
100.3
60.6
66
7
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
5.3
59.4
200
445
KCW96
NOMESCO Finland
Other operations on bladder
27.4
57.3
79
31
U06
ICPC
Haematuria
9.5
57.0
122
143
TKW99
NOMESCO Finland
Other minor surgical procedure in urology
18.9
55.5
86
49
WX408
NOMESCO Finland
General anesthesy, balanced
2.8
50.1
432
2058
KH1BD
NOMESCO Finland
Extensive urinary tract CT examination
15.1
49.7
84
60
C67
ICD-10 Finland
Malignant neoplasm of bladder
60.0
48.9
57
10
WX224
NOMESCO Finland
Blockade of obturius nerve
156.2
43.1
45
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
8.7
39.1
87
108
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
44.5
38.4
47
11
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
3.2
37.4
228
836
WX402
NOMESCO Finland
General anaesthesia
3.1
36.4
236
903
KH1AD
NOMESCO Finland
CT of urinary organs
6.2
35.6
100
175
N30.0
ICD-10 Finland
Acute cystitis
3.4
34.9
186
617
C67.0
ICD-10 Finland
Malignant neoplasm: Trigone of bladder
26.3
34.8
48
19
J01MA02
ATC
ciprofloxacin; systemic
2.2
34.2
548
3411
UKB02
NOMESCO Finland
Retrograde ureteroscopy
10.2
34.2
69
72
4CX01
NOMESCO Finland
NA
124.0
33.9
36
*
KCW02
NOMESCO Finland
Lavation of bladder for coagulated blood
9.6
31.0
64
70
KBJ10
NOMESCO Finland
Cutaneous ureteroenterostomy
18.1
30.3
47
27
ZXC20
NOMESCO Finland
Use of chemical agents
6.8
29.7
77
121
ZXE00
NOMESCO Finland
One hour or less
2.1
29.6
481
2952
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
6.9
29.4
75
115
KCB00
NOMESCO Finland
Biopsy of bladder
28.8
29.0
39
14
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.4
26.4
260
1249
G04BD12
ATC
mirabegron; oral
2.9
25.9
178
694
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.6
25.7
209
904
KCC10
NOMESCO Finland
Cystoprostatectomy
15.7
25.2
41
27
C67.4
ICD-10 Finland
Malignant neoplasm: Posterior wall of bladder
32.9
24.7
32
10
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
6.8
23.9
61
94
8130/2-C67.6
ICD-O-3
Papillary urothelial carcinoma, non-invasive of ureteric orifice
+∞
23.0
22
*
U76
ICPC
Malignant neoplasm of bladder
33.0
22.5
29
9
R33
ICD-10 Finland
Retention of urine
2.6
22.5
184
794
D41.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Renal pelvis
18.4
22.3
34
19
KH1DD
NOMESCO Finland
CT urography of urinary organs
81.8
21.7
24
*
ZXC15
NOMESCO Finland
Use of photodynamic technique
6.8
21.5
55
85
KED22
NOMESCO Finland
Transurethral resection of prostate
2.6
21.0
168
714
C67.1
ICD-10 Finland
Malignant neoplasm: Dome of bladder
24.8
20.9
29
12
C66
ICD-10 Finland
Malignant neoplasm of ureter
19.2
20.0
30
16
C67.5
ICD-10 Finland
Malignant neoplasm: Bladder neck
+∞
19.8
19
*
KDV10
NOMESCO Finland
Internal urethrotomy
6.0
18.5
51
88
G04CA02
ATC
tamsulosin; oral
1.8
18.3
470
3235
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
11.3
18.3
34
31
A98
ICPC
Health maint/preventive medicine
2.3
16.9
990
8841
8130/2-C67.4
ICD-O-3
Papillary urothelial carcinoma, non-invasive of posterior wall of bladder
+∞
16.7
16
*
R82.8
ICD-10 Finland
Abnormal findings on cytological and histological examination of urine
23.5
16.5
23
10
ZXE10
NOMESCO Finland
More than one and less than three hours
1.8
16.3
420
2864
J01EA01
ATC
trimethoprim; systemic
2.0
16.1
241
1361
JN4AD
NOMESCO Finland
Body CT examination
2.5
15.9
136
595
N02BE01
ATC
paracetamol; systemic, rectal
1.9
15.6
911
7909
KA1AE
NOMESCO Finland
Kidney ultrasound examination
4.3
15.5
58
141
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
6.0
15.1
41
70
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
4.4
14.9
54
128
KCD30
NOMESCO Finland
Destruction of tumour of bladder
57.5
14.8
17
*
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
7.0
14.8
36
53
D09.9
ICD-10 Finland
Carcinoma in situ, unspecified
+∞
14.6
14
*
D09.1
ICD-10 Finland
Carcinoma in situ: Other and unspecified urinary organs
+∞
14.6
14
*
UKA02
NOMESCO Finland
Retrograde ureteronephroscopy
12.2
14.1
25
21
KDV12
NOMESCO Finland
Urethroscopic internal urethrotomy
6.1
13.9
37
62
J01MA12
ATC
levofloxacin; systemic
1.8
13.5
258
1581
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.7
13.3
345
2325
C67.3
ICD-10 Finland
Malignant neoplasm: Anterior wall of bladder
50.6
12.9
15
*
ZXD10
NOMESCO Finland
Scheduled procedure
1.6
12.6
412
2952
8120/2-C67.2
ICD-O-3
Urothelial carcinoma in situ of lateral wall of bladder
+∞
12.5
12
*
B02AA02
ATC
tranexamic acid; systemic
2.3
12.2
116
537
C65
ICD-10 Finland
Malignant neoplasm of renal pelvis
16.1
12.2
19
12
D09.3
ICD-10 Finland
Carcinoma in situ: Thyroid and other endocrine glands
+∞
11.5
11
*
WZC30
NOMESCO Finland
Teaching
1.9
11.0
167
937
J01DB01
ATC
cefalexin; oral
1.6
11.0
824
7151
JN3AD
NOMESCO Finland
Abdominal CT examination
2.2
11.0
110
521
KCV22
NOMESCO Finland
Transluminal endoscopic evacuation of blood clots from bladder
21.7
10.7
15
7
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.5
10.7
527
4126
G04CA01
ATC
alfuzosin; oral
1.7
10.3
221
1391
R39.1
ICD-10 Finland
Other difficulties with micturition
3.0
10.3
59
205
SPAT1263
SPAT
Sampling
1.5
10.2
446
3381
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
3.8
10.1
41
110
SPAT1167
SPAT
Insertion of urinary catheter
2.7
10.0
70
273
KBH20
NOMESCO Finland
Replantation of ureter
16.9
9.9
15
9
KC1GB
NOMESCO Finland
Cystography with X-ray
4.7
9.7
32
70
SPAT1312
SPAT
General health counselling
1.6
9.6
313
2203
D41.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Ureter
17.7
9.4
14
8
JN4CD
NOMESCO Finland
Very extensive body CT
2.6
9.4
67
267
8130/2-C67.8
ICD-O-3
Papillary urothelial carcinoma, non-invasive of overlapping lesion of bladder
+∞
9.4
9
*
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
8.1
9.4
20
25
KBV10
NOMESCO Finland
Removal of stent from ureter
7.0
9.3
22
32
U07
ICPC
Urine symptom/complaint other
2.4
9.3
76
327
G04BD08
ATC
solifenacin; oral
2.2
9.1
88
412
N30.9
ICD-10 Finland
Cystitis, unspecified
2.7
9.1
62
242
C67.6
ICD-10 Finland
Malignant neoplasm: Ureteric orifice
37.0
9.0
11
*
KAC21
NOMESCO Finland
Percutaneous endoscopic nephroureterectomy
18.8
8.9
13
7
KH1FT
NOMESCO Finland
Exchange of urinary catheter with radiological guidance
8.0
8.9
19
24
U29
ICPC
Urinary symptom/complaint other
3.3
8.7
42
130
JN4BD
NOMESCO Finland
Extensive body CT
1.8
8.7
150
875
A02BC02
ATC
pantoprazole; systemic
1.5
8.5
661
5586
SPAT1262
SPAT
Handing over of treatment supplies
1.6
8.4
243
1654
WX302
NOMESCO Finland
Thoracal epidural anesthesy
2.5
8.3
66
278
Z71.8
ICD-10 Finland
Other specified counselling
1.7
8.2
195
1258
D30.3
ICD-10 Finland
Benign neoplasm: Bladder
14.6
8.2
13
9
U05
ICPC
Urination problems other
2.4
8.2
68
293
KBD00
NOMESCO Finland
Partial excision of ureter
17.3
8.1
12
7
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
1.7
8.0
162
997
TPH07
NOMESCO Finland
Cathetrisation of artery
1.8
7.9
137
803
R93.4
ICD-10 Finland
Abnormal findings on diagnostic imaging of urinary organs
7.8
7.9
17
22
TKC22
NOMESCO Finland
Catheterisation instruction
3.1
7.9
42
141
C61
ICD-10 Finland
Malignant neoplasm of prostate
1.6
7.8
194
1268
KA3EB
NOMESCO Finland
Antegrade pyelography
7.0
7.8
18
26
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.2
7.6
77
366
KBV00
NOMESCO Finland
Insertion of stent into ureter
7.2
7.5
17
24
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.2
7.4
72
340
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.7
7.3
48
184
Z08.2
ICD-10 Finland
Follow-up examination after chemotherapy for malignant neoplasm
30.2
7.2
9
*
U01
ICPC
Dysuria/painful urination
2.4
7.1
56
238
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.7
7.1
141
865
S18
ICPC
Laceration/cut
1.4
7.0
446
3574
J01CA08
ATC
pivmecillinam; oral
1.6
6.9
206
1408
KDE20
NOMESCO Finland
Removal of foreign body from urethra
4.2
6.8
24
58
N35.9
ICD-10 Finland
Urethral stricture, unspecified
3.9
6.8
26
68
Z3231
NOMESCO Finland
Registered nurse
1.5
6.8
289
2137
D09.7
ICD-10 Finland
Carcinoma in situ of other specified sites
40.3
6.8
8
*
U02
ICPC
Urinary frequency/urgency
1.8
6.7
107
608
N21.0
ICD-10 Finland
Calculus in bladder
4.0
6.7
25
64
WX110
NOMESCO Finland
Local anesthesy
1.4
6.7
620
5296
KA1FN
NOMESCO Finland
Isotope renography
5.5
6.6
18
33
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.3
6.6
58
259
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
1.6
6.6
180
1205
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
2.3
6.4
57
257
KCE02
NOMESCO Finland
Transluminal endoscopic extraction of calculus from bladder
4.4
6.4
21
48
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.4
6.3
450
3659
8130/2-C67.5
ICD-O-3
Papillary urothelial carcinoma, non-invasive of bladder neck
+∞
6.3
6
*
B01AB10
ATC
tinzaparin; parenteral
2.0
6.2
79
416
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.5
6.2
195
1347
B01AB05
ATC
enoxaparin; parenteral
1.4
6.0
319
2452
A03FA01
ATC
metoclopramide; systemic, rectal
1.5
6.0
187
1288
N40
ICD-10 Finland
Hyperplasia of prostate
1.4
6.0
392
3131
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3049717) Cytology report of Urine Cyto stain
875
597
54.36
307.65
7.4
2.5
—
—
—
0
0
(3002256) Pathology report gross observation
561
1293
7.38
255.78
1.9
1.4
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
913
3991
6.76
189.50
9.9
3.4
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
768
2984
5.54
180.91
6.0
3.3
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
629
2357
4.59
147.35
6.6
2.6
e6/l
3.7
3.5
0.15
586
2089
(40768804) Tissue Pathology biopsy report
815
3714
4.89
146.33
3.2
2.3
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
736
3347
4.20
126.28
11.1
3.5
e6/l
504.9
104.0
1.64
676
2683
(3030467) Casts [#/volume] in Urine by Automated count
676
3031
3.89
115.29
10.3
3.4
e6/l
0.2
0.5
8.28
594
2375
(3018095) Leukocytes [#/volume] in Urine
759
3723
3.93
112.00
12.2
3.9
e6/l
160.0
119.9
0.47
703
2828
(3031040) Bacteria [#/volume] in Urine by Automated count
1046
6521
6.46
108.42
14.4
4.6
e6/l
52.4
1868.2
1.18
26
121
(36304419) Bacteria [Presence] in Urine
630
2879
3.56
100.49
10.1
3.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
1035
6677
5.59
95.20
10.0
4.4
—
—
—
0
0
(3026782) Osmolality of Urine
515
2230
3.33
86.69
7.2
2.9
mosm/kgh2o
585.5
576.5
0.51
476
1894
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
441
1908
3.10
71.75
9.4
3.0
e6/l
1.0
1.0
0.08
366
1171
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
422
1804
3.09
69.81
10.4
3.2
e6/l
1.1
1.2
0.08
348
1074
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
784
4695
3.01
69.11
5.9
4.5
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
741
4571
2.68
56.99
8.3
5.1
estimate
0.0
0.0
0.00
201
883
(3035350) Ketones [Presence] in Urine by Test strip
743
4605
2.67
56.33
6.4
3.8
estimate
0.0
0.0
0.00
201
877
(3009261) Glucose [Presence] in Urine by Test strip
744
4652
2.63
54.75
6.4
3.8
estimate
0.0
0.0
0.00
192
843
(3030981) Hyaline casts [#/volume] in Urine by Automated count
197
660
3.38
47.44
8.5
2.8
e6/l
0.2
0.3
2.23
197
651
(3044640) Blood type and Crossmatch panel - Blood
565
3296
2.37
45.47
3.2
2.8
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
867
6180
2.53
43.02
5.8
5.2
mmol/l
6.9
6.9
0.36
843
5837
(40761535) Cells panel - Urine sediment
235
939
2.88
41.42
6.6
3.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
423
2421
2.17
33.02
6.1
3.6
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
533
3456
1.99
28.63
5.1
4.7
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1079
9169
3.14
27.76
24.2
18.2
mg/l
31.4
28.7
1.54
941
7525
(3032080) INR in Blood by Coagulation assay
678
4814
1.96
27.55
12.7
11.9
inr
1.3
1.4
0.98
212
1296
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
538
3564
1.94
26.55
7.2
4.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1037
8685
2.64
26.49
26.0
17.1
ml/min/173m2
70.7
73.7
4.88
948
7244
(3019550) Sodium [Moles/volume] in Serum or Plasma
1112
9762
3.56
24.03
29.9
21.6
mmol/l
139.5
139.6
0.61
1093
9507
(3023103) Potassium [Moles/volume] in Serum or Plasma
1112
9779
3.52
23.60
30.3
21.8
mmol/l
4.0
4.0
0.62
1092
9516
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
931
7581
2.09
23.26
9.4
8.2
u/l
79.6
81.1
0.49
884
7106
(40761536) Microorganisms panel - Urine sediment
176
825
2.33
21.40
6.1
4.0
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
707
5339
1.81
21.16
7.3
6.8
umol/l
10.7
12.7
9.55
678
5085
(40761511) CBC panel - Blood by Automated count
1075
9390
2.69
21.01
24.2
17.5
—
—
—
0
0
(3024731) MCV [Entitic volume]
1117
9970
3.40
20.63
36.7
26.4
fl
91.8
91.9
0.13
1101
9777
(3007461) Platelets [#/volume] in Blood
1117
9970
3.40
20.63
36.8
26.5
e9/l
237.9
232.8
1.83
1090
9667
(3035941) MCH [Entitic mass]
1117
9970
3.40
20.63
36.6
26.4
pg
30.4
30.6
2.58
1101
9775
(3026361) Erythrocytes [#/volume] in Blood
1117
9971
3.40
20.61
36.9
26.5
e12/l
4.4
4.4
0.93
1088
9627
(3010813) Leukocytes [#/volume] in Blood
1117
9973
3.39
20.56
36.9
26.5
e9/l
7.3
7.0
4.59
1088
9626
(3000963) Hemoglobin [Mass/volume] in Blood
1117
9973
3.39
20.56
37.1
26.7
g/l
132.5
134.8
4.60
1101
9779
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
396
2558
1.83
19.65
3.2
2.7
—
—
—
0
0
(4035726)
181
890
2.22
19.55
1.4
1.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
788
6229
1.80
19.38
5.9
5.5
ug/l
2.7
4.1
1.20
704
5528
(3029937) Albumin [Presence] in Urine by Test strip
401
2614
1.81
19.22
7.1
4.2
estimate
0.0
0.0
0.50
179
819
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
690
5290
1.74
18.44
8.0
7.4
mmol/l
1.2
1.2
0.96
577
4451
(3003694) ABO and Rh group [Type] in Blood
373
2411
1.80
18.20
1.4
1.3
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
611
4608
1.68
16.65
6.0
5.1
g/l
34.1
34.5
0.89
570
4272
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1084
9709
2.49
16.41
13.1
11.6
u/l
25.4
26.1
0.70
1042
9298
(3013707) Erythrocyte sedimentation rate by Westergren method
844
6958
1.75
16.32
4.4
4.2
mm/h
16.1
14.0
2.65
751
6336
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
214
1195
1.97
16.29
5.0
3.9
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
340
2224
1.74
15.49
6.0
3.7
—
—
—
0
0
(3013512) EKG study
462
3288
1.67
15.36
5.1
4.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
570
4283
1.64
15.28
2.5
2.2
—
—
—
0
0
(3044889) 12 lead EKG panel
831
6898
1.70
14.81
5.2
4.5
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
381
2598
1.69
14.79
4.9
4.2
%
84.0
82.0
0.79
375
2541
(3013650) Neutrophils [#/volume] in Blood by Automated count
688
5470
1.62
14.27
9.7
9.2
e9/l
4.7
4.4
1.62
598
4769
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
151
783
2.07
14.04
4.4
3.7
mmol/l
1.1
1.9
1.97
118
577
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
158
836
2.03
13.90
4.6
3.7
kpa
5.1
5.1
0.29
149
764
(3009343) pH of Capillary blood
156
822
2.04
13.88
4.7
3.8
ph
7.4
7.4
0.02
18
100
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
621
4839
1.60
13.82
7.1
6.4
mmol/l
1.2
1.2
0.72
558
4368
(3014576) Chloride [Moles/volume] in Serum or Plasma
255
1581
1.78
13.79
7.5
6.9
mmol/l
105.2
104.3
2.65
250
1540
(3009542) Hematocrit [Volume Fraction] of Blood
912
7828
1.74
13.67
25.5
19.6
%
39.0
38.9
0.08
523
4794
(3019069) Monocytes/100 leukocytes in Blood
579
4468
1.58
13.21
6.5
6.3
%
9.0
9.1
0.54
538
4170
(3006504) Eosinophils/100 leukocytes in Blood
577
4451
1.58
13.17
6.2
6.0
%
2.8
2.8
0.33
538
4140
(3002030) Lymphocytes/100 leukocytes in Blood
585
4534
1.58
13.03
6.4
6.2
%
24.2
25.5
1.86
544
4211
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
437
3169
1.60
12.91
3.2
2.6
u/l
54.4
57.5
1.23
410
2935
(3045414) Leukocytes [Presence] in Urine
93
412
2.37
12.73
3.5
1.9
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
455
3340
1.59
12.72
5.3
5.8
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
575
4455
1.57
12.72
6.1
5.9
%
60.1
58.8
1.62
541
4161
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
301
1994
1.68
12.72
2.0
1.9
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
561
4336
1.56
12.45
6.2
6.0
%
0.6
0.6
1.71
524
4042
(3022313) Gas panel - Capillary blood
118
596
2.09
11.73
4.8
3.8
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
612
4873
1.53
11.54
5.9
5.9
e9/l
0.2
0.2
0.15
533
4250
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1011
9068
1.82
11.43
5.7
5.2
mmol/l
6.3
6.2
1.76
876
8087
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
928
8145
1.66
11.17
4.8
4.3
mu/l
2.0
2.1
1.18
796
7236
(3006315) Basophils [#/volume] in Blood
593
4731
1.51
10.81
5.8
5.7
e9/l
0.0
0.0
0.17
507
4055
(3002385) Erythrocyte distribution width [Ratio]
843
7267
1.57
10.55
31.3
22.1
%
14.0
13.9
1.38
829
7098
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
138
779
1.87
9.96
1.9
1.7
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
585
4710
1.48
9.85
5.8
5.7
e9/l
0.7
0.6
1.76
499
4025
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
388
2877
1.52
9.76
2.5
2.2
mg/l
3.2
3.1
0.28
328
2453
(3012516) Albumin [Mass/volume] in Urine
446
3410
1.50
9.66
3.4
3.3
mg/l
200.9
290.5
0.25
316
2297
(3019198) Lymphocytes [#/volume] in Blood
594
4813
1.47
9.59
5.9
5.8
e9/l
1.9
1.9
0.09
523
4204
(3021589) Normoblasts [#/volume] in Blood
525
4154
1.48
9.55
14.3
10.6
e9/l
0.0
0.0
0.40
438
3401
(3000330) Specific gravity of Urine by Test strip
108
576
1.96
9.23
8.2
3.8
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
447
3446
1.48
9.18
3.3
3.2
mmol/l
7.5
7.8
1.00
351
2840
(3022621) pH of Urine by Test strip
122
680
1.89
9.15
4.3
3.0
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
464
3607
1.47
9.12
4.3
4.1
mg/mmol
10.9
9.4
0.23
321
2396
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
32
98
3.33
8.80
1.5
1.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
989
8983
1.63
8.61
5.1
4.9
mmol/l
4.2
4.3
1.67
860
8158
(3014051) Protein [Presence] in Urine by Test strip
56
237
2.43
8.53
4.8
2.2
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
15
26
5.83
8.34
1.0
1.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
90
469
2.00
8.23
2.1
1.8
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1007
9217
1.64
8.15
5.7
5.5
mmol/l
2.4
2.5
1.84
873
8305
(3004789) Transferrin [Mass/volume] in Serum or Plasma
241
1667
1.56
8.13
3.0
2.7
g/l
2.3
2.2
1.19
217
1549
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
750
6464
1.44
8.10
4.0
3.5
pmol/l
15.1
15.0
0.05
631
5682
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
231
1595
1.56
7.83
3.1
2.7
%
18.4
22.8
5.54
195
1367
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
606
5045
1.42
7.82
5.2
4.7
%
20.7
21.7
1.00
347
2688
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
62
286
2.23
7.78
1.5
1.5
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
189
1252
1.61
7.64
3.7
4.3
ug/l
24.9
26.8
0.04
157
1065
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
975
8890
1.57
7.63
5.0
4.8
mmol/l
1.3
1.4
4.19
840
7995
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
88
474
1.93
7.33
3.5
2.7
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
173
1135
1.61
7.27
6.9
7.6
mmol/l
10.8
11.2
0.33
163
1075
(3018418) pH of Serum or Plasma
397
3102
1.42
7.17
4.5
4.3
ph
7.4
7.4
0.16
90
597
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
966
8823
1.53
7.15
7.7
6.7
mmol/mol
42.1
41.1
2.27
864
8035
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
89
487
1.90
7.08
4.2
2.7
u/ml
0.3
0.3
0.37
53
282
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
945
8618
1.49
6.78
4.6
4.3
mmol/l
1.4
1.3
3.67
806
7696
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
14
28
5.05
6.71
2.2
2.0
nmol/l
2.2
8.8
0.44
14
22
(3001122) Ferritin [Mass/volume] in Serum or Plasma
468
3796
1.39
6.69
3.3
2.9
ug/l
162.1
176.8
0.60
411
3442
(3022948) Iron [Moles/volume] in Serum or Plasma
249
1803
1.48
6.67
3.1
2.7
umol/l
10.8
12.4
2.83
229
1676
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
91
512
1.84
6.65
2.4
2.0
—
—
—
0
0
(3019225) pH of Specimen
166
1102
1.59
6.62
5.7
4.6
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
649
5560
1.37
6.57
3.2
3.3
u/l
58.0
60.5
0.23
592
5090
(3042936) Bacteria identified in Isolate by Culture
227
1622
1.50
6.48
2.0
2.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
442
3568
1.38
6.44
3.5
3.3
ug/l
0.7
0.8
0.43
335
2576
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
451
3654
1.38
6.42
3.3
3.2
ng/l
2431.6
1888.4
0.73
400
3222
(3021901) Oxygen saturation in Capillary blood
55
262
2.15
6.42
2.9
3.0
—
—
—
0
0
(3000991) Gas panel - Venous blood
152
1001
1.60
6.27
8.4
8.6
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
352
2753
1.40
6.15
1.6
1.6
nmol/l
19.2
19.5
0.14
289
2343
(3025159) Blasts/100 leukocytes in Blood
119
746
1.66
5.98
4.5
4.4
%
2.5
0.5
0.39
35
230
(3015377) Calcium [Moles/volume] in Serum or Plasma
421
3407
1.37
5.93
4.0
3.5
mmol/l
2.3
2.3
0.18
352
2909
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
536
4509
1.35
5.84
2.2
2.1
pmol/l
91.6
91.8
0.04
298
2499
(3012501) Base excess in Blood by calculation
54
266
2.08
5.81
3.6
5.4
mmol/l
2.5
2.3
0.15
31
172
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
156
1056
1.55
5.71
1.9
2.3
g/l
0.2
0.2
1.01
142
971
(3003458) Phosphate [Moles/volume] in Serum or Plasma
211
1523
1.47
5.68
6.6
6.3
mmol/l
1.0
1.0
0.08
198
1410
(3015235) Bicarbonate [Moles/volume] in Capillary blood
67
360
1.91
5.67
3.7
3.2
mmol/l
24.1
24.8
0.64
59
306
(1616796) Gas panel - Central venous blood
55
276
2.04
5.64
3.0
4.1
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
235
1735
1.44
5.62
31.0
29.4
inr
1.4
1.5
0.32
42
245
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
134
880
1.59
5.59
4.5
4.3
mmol/l
1.2
1.2
0.73
112
772
(3009214) Lutropin [Units/volume] in Serum or Plasma
38
165
2.35
5.56
1.3
1.3
u/l
9.1
7.8
0.36
30
129
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
113
714
1.64
5.51
1.6
1.5
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
194
1387
1.48
5.47
1.8
1.8
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
28
107
2.66
5.34
1.5
1.6
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
166
1157
1.51
5.30
4.3
3.8
mmol/l
1.1
2.0
2.37
126
921
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
436
3605
1.33
5.16
2.1
2.1
nmol/l
79.7
77.7
0.62
362
3126
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
59
314
1.93
5.16
2.2
2.5
ug/min
199.9
114.7
0.29
33
189
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
191
1378
1.46
5.14
1.7
1.9
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
122
801
1.58
5.10
4.5
4.4
%
0.2
0.1
0.32
41
278
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
105
668
1.63
5.00
8.5
10.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
151
1046
1.51
4.96
1.4
1.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
175
1251
1.47
4.93
1.9
1.8
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
507
4304
1.31
4.92
5.3
4.2
ng/l
44.2
67.5
1.13
434
3386
(3042631) Mycobacterium sp identified in Specimen
38
175
2.21
4.88
2.7
2.6
—
—
—
0
0
(3012544) pH of Venous blood
168
1194
1.47
4.87
4.5
3.9
—
7.4
—
0
8
(3052851) Hemolysis interference index of Serum or Plasma
58
318
1.87
4.66
4.1
3.8
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
51
268
1.94
4.65
2.6
2.7
%
15.4
15.8
0.28
27
142
(3017181) Myelocytes/100 leukocytes in Blood
127
861
1.53
4.62
4.7
4.3
%
0.9
0.8
0.10
42
305
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
120
804
1.55
4.60
8.2
8.7
%
1.2
1.3
0.69
120
798
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
119
798
1.55
4.55
8.4
8.9
%
0.5
0.7
3.50
119
791
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
60
338
1.82
4.44
1.6
1.7
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
254
1976
1.36
4.40
1.7
1.7
mg/l
1.7
1.5
0.37
200
1560
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
23
89
2.62
4.32
1.1
1.2
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
113
760
1.54
4.27
4.5
4.2
%
0.9
0.6
0.64
33
212
(3006184) Hemoglobin [Mass/volume] in Capillary blood
49
265
1.89
4.14
2.3
2.4
g/l
123.5
129.3
0.61
36
200
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
23
92
2.53
4.06
1.0
1.3
nmol/l
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
31
143
2.20
4.01
1.4
1.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
25
105
2.41
4.00
1.5
1.4
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
86
553
1.60
3.96
4.7
4.0
mmol/l
23.5
24.1
1.06
74
499
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
14
43
3.28
3.91
5.4
6.9
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
175
1311
1.39
3.80
1.3
1.3
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
273
2192
1.32
3.79
4.4
4.1
ng/l
468.9
374.8
0.16
235
1905
(3028271) Lactate [Moles/volume] in Capillary blood
39
203
1.95
3.71
1.9
2.0
mmol/l
1.7
1.8
0.25
39
198
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
389
3286
1.27
3.65
2.5
2.2
u/l
208.2
253.5
0.40
357
3058
(3012095) Magnesium [Moles/volume] in Serum or Plasma
230
1811
1.34
3.65
3.9
3.3
mmol/l
0.8
0.8
0.00
214
1697
(3027945) Reticulocytes/100 erythrocytes in Blood
197
1516
1.36
3.63
2.9
2.5
%
1.7
1.8
0.34
177
1346
(3036481) Cortisol [Moles/volume] in Serum or Plasma
117
822
1.47
3.62
3.6
2.2
nmol/l
351.0
370.3
0.40
111
748
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
158
1178
1.39
3.53
2.7
2.9
umol/l
8.6
10.4
0.30
143
1056
(1761482) Bacteria [#/volume] in Urine by Culture
55
325
1.73
3.52
10.4
4.8
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
258
2081
1.31
3.44
7.8
4.2
kg/l
1.0
1.0
0.02
39
309
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
98
672
1.50
3.42
8.9
9.3
mmol/l
23.6
24.3
2.18
93
625
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
10
27
3.73
3.36
2.2
2.7
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
126
915
1.42
3.28
2.6
2.5
u/l
31.5
36.5
0.84
110
781
(3022806) Fractional oxyhemoglobin in Capillary blood
32
163
1.99
3.26
1.9
1.9
%
88.9
89.1
0.08
32
163
(3026493) Urate [Moles/volume] in Serum or Plasma
340
2863
1.26
3.21
3.1
3.0
umol/l
6845.7
7065.6
0.02
269
2429
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
184
1430
1.34
3.18
3.3
4.2
u/l
221.9
251.9
3.55
174
1346
(3003396) Base excess in Arterial blood by calculation
188
1470
1.33
3.12
7.1
7.2
mmol/l
0.2
1.1
2.56
152
1122
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
188
1470
1.33
3.12
7.1
7.2
kpa
5.0
5.1
0.27
181
1396
(3027801) Oxygen [Partial pressure] in Arterial blood
188
1471
1.33
3.10
7.1
7.2
kpa
12.0
11.7
0.32
180
1398
(3004809) Band form neutrophils/100 leukocytes in Blood
38
210
1.84
3.07
3.7
4.2
%
0.7
1.4
1.08
25
164
(3017732) Neutrophils [#/volume] in Blood
89
614
1.49
3.04
3.2
3.4
e9/l
4.5
4.3
0.45
61
450
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
111
813
1.40
2.78
1.6
1.6
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
287
2406
1.26
2.77
1.8
1.8
pmol/l
428.7
9524231.5
1.00
216
1974
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
66
438
1.54
2.73
4.2
3.6
u/ml
73.8
9392.3
0.84
57
371
(3051611) Lipemic interference index of Serum or Plasma
22
105
2.12
2.70
3.5
3.5
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
148
1145
1.33
2.65
2.4
2.7
e9/l
62.0
68.9
1.58
117
904
(3035320) C reactive protein [Mass/volume] in Body fluid
16
67
2.41
2.64
2.8
2.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
230
1896
1.26
2.55
5.3
4.7
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
349
3017
1.22
2.52
3.1
3.3
u/l
46.6
35.3
0.58
322
2864
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
113
846
1.37
2.51
3.3
3.2
ml/min/173m2
57.8
60.8
0.37
49
356
(3000494) Fungus identified in Specimen by Culture
151
1183
1.32
2.48
1.5
1.4
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
30
166
1.83
2.46
1.7
1.6
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
83
591
1.44
2.46
2.0
1.9
ug/l
1.2
2.6
0.81
73
522
(3012565) Volume of 24 hour Urine
13
51
2.57
2.45
1.5
3.1
ml
1712.9
1948.1
—
7
42
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
6
12
5.02
2.40
1.3
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
29
161
1.82
2.37
1.5
1.5
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
15
65
2.32
2.32
3.5
3.2
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
57
382
1.52
2.29
2.9
3.6
pmol/l
4.3
4.3
0.00
52
331
(3023323) Follitropin [Units/volume] in Serum or Plasma
16
72
2.24
2.28
1.1
1.3
iu/l
24.0
22.8
0.07
11
64
(3021387) Prolactin [Units/volume] in Serum or Plasma
25
134
1.88
2.28
1.5
1.7
mu/l
326.8
288.1
0.16
25
123
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
241
2024
1.24
2.27
3.9
3.2
mmol/l
2.5
2.5
1.28
214
1762
(40757373) Influenza virus identified in Isolate
8
23
3.49
2.27
2.5
1.5
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
41
256
1.62
2.23
1.3
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
41
256
1.62
2.23
1.3
1.3
—
—
—
0
0
(4024509)
20
100
2.02
2.21
1.4
1.3
—
—
—
0
0
(40768441) Liver Pathology biopsy report
15
67
2.25
2.18
1.2
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
305
2636
1.21
2.17
3.8
3.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
78
563
1.41
2.17
2.7
2.5
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
19
94
2.04
2.16
1.1
1.3
—
—
—
0
0
(3000492) Spirometry study
100
754
1.36
2.15
1.6
1.5
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
9
30
3.01
2.15
1.3
1.4
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
31
182
1.72
2.13
1.1
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
15
68
2.22
2.11
1.2
1.4
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
61
424
1.46
2.08
1.2
1.2
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
20
103
1.96
2.06
1.5
2.4
ml
825.8
639.2
—
8
65
(40768443) Skin Pathology biopsy report
61
426
1.46
2.04
1.2
1.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
270
2322
1.21
2.01
1.9
1.8
nmol/l
1125.4
1148.5
0.15
188
1757
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
36
224
1.63
2.01
1.2
1.3
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
17
84
2.04
1.96
1.1
1.4
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
85
635
1.36
1.96
1.6
1.9
g/l
1.7
1.5
1.47
77
544
(3024891) Influenza virus A+B Ag [Presence] in Specimen
34
211
1.63
1.93
1.1
1.2
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
7
22
3.19
1.88
1.0
1.0
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
53
0.00
1.87
0.0
1.0
—
—
—
0
0
(3026480) Teichoate Ab [Titer] in Serum
5
12
4.18
1.82
1.2
1.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
130
1044
1.28
1.81
1.3
1.3
titre
416.0
475.1
0.21
25
235
(3040151) Glucose [Moles/volume] in Capillary blood
26
153
1.72
1.80
5.2
6.7
mmol/l
7.4
7.1
0.21
21
128
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
77
577
1.36
1.76
3.4
2.7
%
1.4
1.1
0.82
77
572
(3037121) Protein [Mass/volume] in Urine
58
415
1.42
1.74
3.2
2.8
g/l
0.4
0.3
0.49
31
166
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
40
266
1.52
1.73
2.1
3.6
u/ml
419.6
1251.2
0.40
35
251
(3008757) Leukocyte morphology finding [Identifier] in Blood
24
141
1.72
1.69
5.2
4.9
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
159
1325
1.23
1.63
5.0
4.9
%
32.9
32.4
0.23
99
867
(3033705) Calcium.ionized [Moles/volume] in Venous blood
27
166
1.64
1.62
2.6
2.8
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
12
56
2.15
1.61
1.2
1.7
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
12
56
2.15
1.61
1.2
1.7
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
22
128
1.73
1.61
1.7
1.6
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
22
128
1.73
1.61
4.7
2.8
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
13
63
2.08
1.60
1.2
1.4
promille
2.0
1.1
—
8
48
(3008037) Lactate [Moles/volume] in Venous blood
43
296
1.47
1.60
3.9
3.5
mmol/l
1.6
1.6
0.17
43
290
(3017354) Segmented neutrophils/100 leukocytes in Blood
23
136
1.70
1.59
3.1
4.2
%
63.8
55.8
0.61
12
88
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
17
92
1.86
1.56
2.4
1.9
u/field
1.1
1.8
—
8
29
(3009445) Proteinase 3 Ab [Units/volume] in Serum
60
444
1.37
1.51
2.4
1.4
u/ml
14.7
31.8
—
5
7
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
22
132
1.68
1.46
1.5
1.5
%
61.8
64.2
0.09
13
89
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
11
52
2.13
1.44
3.5
3.3
u/l
247.2
221.4
0.22
11
52
(3038515) Glucose [Moles/volume] in Venous blood
40
278
1.45
1.44
4.0
3.7
mmol/l
7.5
7.7
0.13
40
273
(4034850)
19
313
0.60
1.41
17.3
12.6
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
27
174
1.56
1.38
1.4
1.5
e6/l
27750.8
68123.5
0.89
17
107
(3003338) MCHC [Mass/volume]
760
7241
1.14
1.37
33.2
24.2
g/l
330.8
332.3
4.38
752
7185
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
54
401
1.36
1.36
1.3
1.4
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
137
1149
1.22
1.34
2.9
2.6
ug/l
6.3
7.1
0.24
121
1021
(3016750) Collection duration of Urine
14
75
1.88
1.34
1.4
2.3
min
538.6
497.3
—
5
52
(40758558) Short blood count panel - Blood
267
2380
1.16
1.30
8.4
6.8
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
9
43
2.10
1.30
2.2
1.3
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
29
193
1.52
1.30
1.7
1.5
—
—
—
0
0
(3019977) pH of Arterial blood
14
76
1.85
1.30
1.9
3.5
ph
7.4
7.4
—
6
27
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
36
251
1.45
1.29
1.6
1.6
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
22
138
1.61
1.27
1.2
1.1
iu/ml
1.0
34.7
—
5
28
(3044242) Glucose [Moles/volume] in Arterial blood
14
77
1.83
1.25
1.6
2.7
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
16
92
1.75
1.25
1.3
1.6
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
11
56
1.97
1.22
1.1
1.2
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
5
19
2.64
1.21
2.6
2.6
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
8
37
2.17
1.21
5.4
2.8
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
13
71
1.84
1.19
3.2
2.8
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
36
256
1.42
1.19
2.4
2.4
%
214.9
207.0
0.20
36
240
(3042733) HLA Ab [Presence] in Serum
6
26
2.31
1.19
2.2
4.7
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
8
38
2.11
1.18
2.1
2.5
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
39
282
1.40
1.17
1.4
1.5
ug/g
216.4
259.0
0.71
21
179
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
72
1.81
1.15
1.2
1.6
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
5
20
2.51
1.15
2.6
2.5
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
5
20
2.51
1.15
1.2
1.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
44
327
1.36
1.13
2.5
3.7
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
277
2501
1.14
1.13
1.6
1.6
mmol/l
1.4
1.3
1.03
212
2042
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
18
111
1.63
1.12
1.2
1.4
u/l
15.4
13.8
0.20
18
105
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
18
111
1.63
1.12
1.2
1.3
u/l
13.5
13.3
0.02
18
105
(3017446) Testosterone [Moles/volume] in Serum or Plasma
116
977
1.21
1.12
2.1
2.2
nmol/l
10.2
12.5
2.73
100
837
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
24
160
1.51
1.10
1.5
1.5
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
35
252
1.40
1.09
4.8
2.9
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
5
21
2.39
1.09
1.0
1.1
—
—
—
0
0
(3000012) Reticulocyte production index
11
59
1.87
1.07
1.1
1.7
—
—
—
0
0
(4146454)
21
137
1.54
1.06
2.3
2.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
28
195
1.45
1.05
1.5
1.5
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
14
228
0.61
1.04
1.4
1.7
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
9
46
1.96
1.03
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
9
46
1.96
1.03
1.0
1.0
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
5
108
0.46
1.01
2.0
1.8
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
5
108
0.46
1.01
2.0
1.8
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
5
108
0.46
1.01
2.0
1.8
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
22
148
1.50
0.98
1.0
1.2
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
5
23
2.18
0.98
1.6
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
99
835
1.20
0.97
1.2
1.3
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
10
54
1.86
0.96
5.4
3.9
nmol/l
87.4
94.7
—
10
54
(3006922) Hepatitis E virus Ab [Presence] in Serum
9
50
1.81
0.96
1.0
1.1
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
6
27
2.23
0.93
1.5
1.3
—
—
—
0
0
(3024471) HLA-A [Type]
6
27
2.23
0.93
1.0
1.0
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
17
110
1.55
0.91
1.2
1.7
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
16
102
1.58
0.90
2.3
1.2
u/ml
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
6
29
2.07
0.89
1.5
2.0
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
12
71
1.70
0.89
1.8
2.9
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
33
246
1.35
0.88
5.5
4.0
mg/l
29.9
29.8
0.00
21
159
(40768795) Lymph node Pathology biopsy report
14
87
1.62
0.87
1.1
1.2
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
53
423
1.26
0.87
3.9
3.6
ratio
1.1
1.9
—
6
36
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
15
95
1.59
0.87
2.3
1.7
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
35
264
1.34
0.87
1.7
1.5
iu/ml
1.4
24.5
—
9
55
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
25
179
1.41
0.84
2.7
1.5
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
54
435
1.25
0.83
3.8
3.6
mg/l
56.7
73.6
0.49
39
358
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
54
435
1.25
0.83
3.8
3.6
mg/l
83.9
85.4
0.01
39
361
(3023419) Bacteria identified in Sputum by Culture
24
172
1.40
0.81
1.6
2.2
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
71
592
1.21
0.81
5.3
4.2
%
48.5
47.7
0.11
71
585
(3000285) Sodium [Moles/volume] in Blood
0
24
0.00
0.79
0.0
1.0
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
33
251
1.32
0.79
1.5
1.6
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
37
288
1.29
0.76
1.3
1.6
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
26
192
1.36
0.75
1.5
1.5
e6/l
1540.0
1623.9
0.06
20
138
(3052592) Norovirus Ag [Presence] in Stool
5
24
2.09
0.74
1.0
1.5
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
5
24
2.09
0.74
1.0
1.1
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
92
793
1.17
0.74
4.7
4.2
ng/l
107.5
102.7
0.16
76
685
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
9
54
1.67
0.74
1.6
1.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
43
343
1.26
0.74
1.2
1.6
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
38
300
1.28
0.71
1.3
1.4
—
—
—
0
0
(3024932) HLA-DR beta [Type]
5
26
1.93
0.70
1.0
1.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
92
798
1.17
0.70
1.9
1.5
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
41
1.71
0.70
2.0
2.9
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
41
1.71
0.70
2.0
2.9
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
23
169
1.37
0.69
3.5
4.0
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
5
27
1.86
0.68
1.0
3.4
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
7
42
1.67
0.68
1.7
2.2
—
—
—
0
0
(4015189)
7
42
1.67
0.68
2.3
1.9
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
7
42
1.67
0.68
1.3
1.3
%
43.9
25.8
—
7
29
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
9
59
1.53
0.68
2.7
2.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
32
249
1.29
0.67
1.5
1.5
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7
120
0.58
0.67
1.7
1.9
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
35
276
1.28
0.67
1.5
1.5
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
5
28
1.79
0.66
2.0
1.5
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
5
28
1.79
0.66
3.0
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
10
155
0.64
0.66
1.3
1.3
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
44
360
1.23
0.63
1.2
1.3
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
11
71
1.55
0.62
1.1
1.2
—
—
—
0
0
(44806420)
8
50
1.60
0.61
2.6
2.3
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
21
0.00
0.60
0.0
3.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
10
64
1.57
0.58
1.6
2.5
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
8
53
1.51
0.58
1.0
1.1
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
16
219
0.73
0.58
1.3
1.2
—
5.2
—
0
6
(3019897) Erythrocyte distribution width [Ratio] by Automated count
6
35
1.72
0.57
6.0
5.5
%
13.3
13.3
—
6
35
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
8
54
1.48
0.57
1.0
1.2
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
6
37
1.62
0.55
60.8
31.9
ug/l
6.8
7.2
—
6
32
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
10
65
1.54
0.55
3.1
3.7
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
46
385
1.20
0.55
5.3
6.2
mmol/l
1.3
1.4
0.67
40
332
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
8
125
0.64
0.54
1.7
1.9
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
14
193
0.72
0.53
1.7
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
12
169
0.71
0.52
1.2
1.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
89
792
1.13
0.51
1.9
1.6
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
16
214
0.74
0.51
1.3
1.2
mmol/l
4.0
3.9
0.09
16
196
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
19
247
0.77
0.50
1.3
1.2
mg/l
754.5
551.1
0.51
19
228
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
16
213
0.75
0.50
1.7
1.3
e6/l
17.3
45.9
—
10
171
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
16
213
0.75
0.50
1.8
1.3
e6/l
1072.7
751.2
0.12
11
176
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
6
41
1.47
0.50
1.3
1.5
—
—
—
0
0
(3004451) EKG impression Narrative
10
67
1.50
0.49
1.7
1.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
20
154
1.30
0.48
1.2
1.5
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
55
475
1.17
0.48
4.3
3.9
mmol/l
1.3
1.4
0.19
55
468
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
17
128
1.33
0.47
1.3
1.5
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
18
137
1.32
0.47
3.1
4.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
98
884
1.12
0.47
2.6
2.5
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
7
49
1.43
0.46
1.0
2.1
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
5
82
0.61
0.46
1.8
2.0
ug/l
1.4
2.2
—
5
68
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
11
77
1.43
0.45
1.1
1.2
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
34
283
1.21
0.45
3.0
3.2
nmol/l
0.8
0.8
0.02
28
220
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
21
165
1.28
0.45
1.7
1.6
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
33
274
1.21
0.45
1.7
1.7
e6/l
13948.3
17782.2
0.36
23
201
(3023183) Ammonium ion [Moles/volume] in Plasma
23
286
0.80
0.45
2.4
3.0
umol/l
32.4
34.5
0.18
16
228
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
12
86
1.40
0.44
1.0
1.0
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
17
130
1.31
0.44
1.3
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
17
130
1.31
0.44
1.3
1.6
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
19
148
1.29
0.43
1.4
1.5
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
5
31
1.62
0.43
1.0
1.1
u/ml
—
24.8
—
0
5
(21494755) Public health laboratory ask at order entry panel
27
327
0.82
0.42
1.4
1.4
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.9
—
16.1
—
0
16
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
26
213
1.23
0.41
1.1
1.3
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
8
59
1.36
0.41
1.4
2.3
%
71.4
70.8
—
8
53
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
11
79
1.40
0.40
1.5
1.3
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
11
79
1.40
0.40
2.2
2.3
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
19
238
0.80
0.40
1.5
1.5
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
5
34
1.47
0.40
2.2
1.9
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.8
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
8
61
1.31
0.39
1.5
1.5
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
8
61
1.31
0.39
1.5
1.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
33
388
0.85
0.39
2.0
1.8
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
46
401
1.15
0.38
1.3
1.7
u/l
37.3
38.1
0.12
37
343
(3051593) INR in Capillary blood by Coagulation assay
9
67
1.35
0.38
2.9
17.5
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
12
89
1.35
0.38
1.3
1.2
nmol/l
1.2
1.5
0.64
12
80
(3004616) Nuclear Ab [Presence] in Serum
8
115
0.69
0.37
1.4
1.3
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
90
822
1.10
0.37
7.4
6.9
mmol/l
24.3
24.5
0.12
85
762
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
21
171
1.23
0.36
1.2
1.4
—
—
—
0
0
(4281824)
10
73
1.37
0.34
1.3
1.3
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
6
44
1.37
0.34
1.2
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
40
349
1.15
0.34
1.1
1.2
iu/ml
158.4
151.5
—
9
123
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
6
45
1.34
0.33
1.0
1.6
u/ml
1628.8
1439.5
—
6
45
(21494890) Protein electrophoresis panel - 24 hour Urine
11
144
0.76
0.33
1.5
2.3
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
10
74
1.35
0.32
1.0
1.5
—
241.4
—
0
7
(3020630) Protein [Mass/volume] in Serum or Plasma
113
1052
1.08
0.32
2.6
2.8
g/l
66.0
66.2
0.09
101
961
(3011648) Oxygen content in Venous blood
12
92
1.31
0.32
1.4
1.8
%
10.0
10.8
0.21
12
92
(3021879) Hepatitis B virus core Ab [Presence] in Serum
55
495
1.12
0.31
1.4
1.4
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
31
268
1.16
0.30
1.3
1.2
—
0.9
—
0
26
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
21
175
1.20
0.30
1.2
1.5
—
—
—
0
0
(3019060) Gas panel - Arterial blood
95
881
1.09
0.30
4.8
4.6
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
13
102
1.28
0.30
1.2
1.3
%
14.7
26.0
—
7
69
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
14
174
0.80
0.29
1.3
1.1
—
1.8
—
0
9
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
19
157
1.21
0.29
1.7
2.5
mg/l
13.2
19.7
—
5
36
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
26
222
1.18
0.29
1.2
1.2
u/l
49.9
59.7
0.13
26
195
(40768793) Breast Pathology biopsy report
8
109
0.73
0.29
1.6
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
16
130
1.23
0.28
1.3
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
16
130
1.23
0.28
1.3
1.5
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
119
1117
1.07
0.28
3.6
3.1
ng/l
301.5
246.1
0.59
110
1019
(4062490)
10
76
1.32
0.28
1.8
1.3
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
8
62
1.29
0.28
1.0
1.2
nmol/l
—
5.9
—
0
13
(3036782) Glucose [Moles/volume] in Pleural fluid
18
149
1.21
0.28
1.6
1.5
mmol/l
7.3
6.5
0.70
18
140
(3005988) Vibrio sp identified in Specimen by Organism specific culture
16
131
1.22
0.27
1.3
1.5
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
163
1551
1.06
0.26
1.2
1.2
u/ml
2.0
1.4
0.30
32
382
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
8
67
1.20
0.26
2.5
2.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
31
272
1.14
0.26
1.7
1.7
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
134
1268
1.06
0.26
1.2
1.3
iu/ml
23.0
44.3
2.13
36
387
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
9
76
1.19
0.24
1.4
1.5
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
9
76
1.19
0.24
1.4
1.5
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
9
76
1.19
0.24
8.2
3.6
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
11
87
1.27
0.24
1.1
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
140
1334
1.06
0.22
8.2
8.4
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
7
91
0.77
0.22
2.0
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
13
157
0.83
0.22
1.2
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
25
219
1.14
0.22
1.2
1.5
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
12
146
0.82
0.22
1.0
1.1
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3001729) Color of Synovial fluid
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3035611) Eosinophils/100 leukocytes in Synovial fluid
0
10
0.00
0.21
0.0
1.1
—
0.3
—
0
5
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
23
201
1.15
0.21
1.9
1.8
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
8
105
0.76
0.21
2.3
1.2
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
5
43
1.16
0.21
1.6
2.4
—
—
—
0
0
(44813793)
5
43
1.16
0.21
1.2
1.0
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
32
287
1.12
0.21
1.8
1.7
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
13
0.00
0.21
0.0
3.5
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
13
0.00
0.21
0.0
2.0
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
19
164
1.16
0.20
1.8
1.4
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
10
123
0.81
0.20
2.5
2.5
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
12
144
0.83
0.20
1.4
1.6
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
49
453
1.09
0.19
3.3
2.7
g/l
3.2
3.1
0.15
35
356
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
6
53
1.13
0.18
1.0
2.7
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
57
531
1.08
0.18
1.1
1.3
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
5
67
0.75
0.17
1.2
1.4
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
5
67
0.75
0.17
1.2
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
98
936
1.05
0.16
1.9
1.5
—
—
—
0
0
(4268621)
6
76
0.79
0.15
2.7
2.3
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
6
77
0.78
0.15
1.0
1.2
mmol/l
30.3
35.8
—
6
69
(3038026) Centromere Ab [Units/volume] in Serum
6
77
0.78
0.15
1.3
1.1
—
55.3
—
0
5
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
26
286
0.91
0.15
1.1
1.0
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
52
488
1.07
0.15
3.2
2.6
g/l
3.9
3.9
0.01
35
350
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
52
488
1.07
0.15
3.2
2.6
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
52
488
1.07
0.15
3.2
2.6
g/l
7.5
7.3
0.25
35
363
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
83
870
0.95
0.15
1.2
1.8
%
1.7
1.6
0.32
66
713
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
9
82
1.10
0.15
1.2
1.2
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
27
246
1.10
0.14
1.6
1.8
mg/l
10.8
12.4
0.37
21
223
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
27
295
0.91
0.14
1.3
1.2
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
21
189
1.11
0.13
3.8
3.2
%
58.7
59.7
0.10
21
189
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
8
98
0.82
0.13
1.0
1.0
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
152
1474
1.04
0.13
1.6
1.5
g/l
3.1
3.0
0.17
94
871
(3030905) Polymorphonuclear cells [#/volume] in Blood
20
180
1.11
0.13
3.4
2.9
e9/l
5.3
4.7
0.52
20
180
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
45
423
1.07
0.13
4.1
2.8
g/l
1.2
1.5
0.17
33
369
(3020891) Body temperature
53
505
1.05
0.10
5.3
4.6
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
19
208
0.91
0.10
1.4
1.3
nmol/l
1.2
0.8
0.98
12
168
(36660697) Celiac disease serology panel - Serum
57
545
1.05
0.10
1.2
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
88
851
1.04
0.10
1.5
1.5
—
—
—
0
0
(44790049)
12
135
0.89
0.10
2.1
1.5
—
—
—
0
0
(44790048)
12
135
0.89
0.10
2.1
1.5
—
—
—
0
0
(44806118)
12
135
0.89
0.10
2.1
1.5
—
—
—
0
0
(44790047)
12
135
0.89
0.10
2.1
1.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
20
217
0.92
0.09
1.5
1.6
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
5
48
1.04
0.09
3.8
3.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
6
54
1.11
0.09
1.0
1.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
6
56
1.07
0.08
1.3
2.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
27
253
1.07
0.08
1.1
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
6
57
1.05
0.08
1.0
1.1
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
6
57
1.05
0.08
3.5
2.5
e9/l
0.3
0.2
—
6
52
(3002523) Influenza virus A Ag [Presence] in Specimen
6
57
1.05
0.08
1.0
1.1
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
6
58
1.03
0.08
1.5
2.9
mmol/l
10.7
9.3
—
6
48
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
5
62
0.81
0.08
2.0
2.1
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
5
62
0.81
0.08
2.0
2.1
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
5
62
0.81
0.08
2.0
2.1
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
5
62
0.81
0.08
2.0
2.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
5
63
0.79
0.08
1.4
1.3
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
5
63
0.79
0.08
1.0
1.1
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
5
64
0.78
0.08
1.8
1.6
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
8
76
1.05
0.07
1.0
1.0
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
24
255
0.94
0.07
4.1
1.7
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
27
255
1.06
0.07
1.1
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
47
452
1.04
0.07
1.2
1.3
—
—
—
0
0
(3035880) pH of Pleural fluid
9
87
1.03
0.07
1.8
1.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
9
101
0.89
0.06
1.1
1.1
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
9
102
0.88
0.06
1.7
2.0
mg/l
4.1
4.7
—
9
97
(3042111) Morphology [Interpretation] in Bone marrow Narrative
26
246
1.06
0.06
1.3
1.6
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
33
315
1.05
0.06
1.1
1.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
79
770
1.03
0.06
2.3
2.2
ug/g
171.1
162.8
0.07
58
604
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
19
178
1.07
0.05
1.1
1.1
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
14
151
0.93
0.05
1.1
1.1
g/l
1.4
1.6
1.20
14
137
(3045142) Bone marrow Pathology biopsy report
16
149
1.07
0.05
1.0
1.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
15
140
1.07
0.04
1.1
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
17
160
1.06
0.04
1.1
1.1
—
—
—
0
0
(4094501)
24
251
0.96
0.04
1.1
1.1
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
47
458
1.03
0.03
3.4
2.7
g/l
10.4
10.8
0.29
36
388
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
33
341
0.97
0.03
4.4
2.7
g/l
0.0
0.0
0.00
28
315
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
26
250
1.04
0.03
1.1
1.2
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
60
588
1.02
0.03
1.6
1.9
g/l
1.1
1.6
1.37
54
531
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
11
118
0.93
0.02
1.0
1.0
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
41
400
1.03
0.02
4.9
4.0
mmol/l
4.0
4.0
0.03
34
368
(3008898) HLA-B27 [Presence]
17
162
1.05
0.02
1.0
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
10
93
1.08
0.02
1.1
1.1
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
15
157
0.95
0.01
1.1
1.2
u/ml
285.5
321.2
—
6
82
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
16
167
0.96
0.01
1.5
1.4
—
—
—
0
0
(1002224) Polysomnography panel
23
223
1.03
0.01
1.0
1.1
—
—
—
0
0
(4306422)
11
104
1.06
0.01
1.4
1.2
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
10
106
0.94
0.01
1.3
1.2
u/ml
14.0
5.6
—
5
50
(3000093) Morphology [Interpretation] in Blood Narrative
11
116
0.95
0.00
1.2
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
13
124
1.05
0.00
1.5
1.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
27
264
1.02
0.00
1.5
1.4
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
10
104
0.96
0.00
1.1
1.1
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
36
364
0.99
0.00
4.1
2.7
g/l
0.4
0.0
0.62
31
338
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
19
192
0.99
0.00
1.4
1.7
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
121
1214
1.00
0.00
1.2
1.2
u/ml
5.5
14.9
1.73
32
423
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
17
171
0.99
0.00
1.5
1.4
—
20.4
—
0
5
(3048929) Epstein Barr virus Ab [Presence] in Serum
21
207
1.01
0.00
1.1
1.2
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
38
383
0.99
0.00
4.0
2.6
g/l
35.8
37.1
0.54
29
331
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
26
265
0.98
0.00
1.2
1.8
nmol/l
43.0
44.5
0.13
26
248
(4010399)
72
725
0.99
0.00
1.5
1.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
16
165
0.97
0.00
1.2
1.2
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
15
145
1.03
0.00
1.5
1.4
u/ml
98.9
136.7
—
7
24
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
16
155
1.03
0.00
1.3
1.3
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
9
95
0.95
0.00
1.9
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
7
75
0.93
0.00
1.0
1.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
7
75
0.93
0.00
1.0
1.5
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
6
59
1.02
0.00
3.5
2.5
e6/l
774.0
578.4
—
6
52
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
6
62
0.97
0.00
1.2
1.6
u/l
—
9.8
—
0
32
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
7
72
0.97
0.00
1.1
1.1
mmol/l
2.3
2.1
—
7
66
(40758358) Immune stain study
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
7
72
0.97
0.00
1.3
1.1
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
0
6
0.00
0.00
0.0
2.8
—
—
—
0
0
(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.0
—
39.7
—
0
5
(3044009) aPTT.lupus sensitive (LA screen)
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
6
63
0.95
0.00
1.2
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3013762) Body weight Measured
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3017704) Immunofixation for Urine
9
91
0.99
0.00
1.0
1.6
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
54
0.93
0.00
1.0
1.1
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
7
77
0.91
0.00
1.0
1.2
%
99.9
95.1
—
7
72
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
6
0.00
0.00
0.0
4.8
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
6
63
0.95
0.00
1.2
1.1
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
6
63
0.95
0.00
1.2
1.1
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
6
67
0.89
0.00
2.0
1.8
—
46.7
—
0
5
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.6
—
23.1
—
0
9
(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.0
—
21.3
—
0
5
(3050129) First trimester maternal screen panel - Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
0
6
0.00
0.00
0.0
1.5
—
935.7
—
0
6
(40763480) Human metapneumovirus Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
6
61
0.98
0.00
1.2
1.1
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
5
57
0.88
0.00
1.0
1.1
nmol/l
145.0
135.5
—
5
57
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
419.6
—
0
5
(3027944) Amphetamines [Presence] in Urine
7
74
0.95
0.00
1.0
1.5
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
5
59
0.85
0.00
1.0
1.3
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
6
59
1.02
0.00
1.0
1.0
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(4211845)
5
52
0.96
0.00
3.8
3.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
8
89
0.90
0.00
1.0
1.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
7
73
0.96
0.00
1.0
1.5
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
6
61
0.98
0.00
1.2
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
62
0.97
0.00
1.2
1.1
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
2.3
—
0
6
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
6
61
0.98
0.00
1.2
1.1
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
4.9
—
0.2
—
0
9
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
7
74
0.95
0.00
1.0
1.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
5
50
1.00
0.00
2.6
1.2
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.0
—
7.4
—
0
5
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
7
73
0.96
0.00
1.0
1.5
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3044416) Complement C4 [Mass/volume] in Pleural fluid
0
9
0.00
0.00
0.0
1.0
—
0.1
—
0
9
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_OTHER_NOS – Carcinoma in situ of other and unspecified sites
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).